Topic summary

Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile

Compounds › Semaglutide STEP programme type 2 diabetes randomised trial SELECT trial semaglutide

This is a generated summary. It shows the 9 most-liked posts from a topic of 123, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

t.lindqvistTL225 Apr 2026#8

b.brandt, post #6: On post #2 — agreed on the reasoning, with one qualification. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a fatty side chain, which creates a very long half-life at the cost of sequestering the free form. That is a… Go to post

Counter-ion form matters for the arithmetic and is almost never stated. A vial labelled 5 mg of peptide as an acetate salt and one labelled 5 mg as trifluoroacetate do not contain the same quantity of the molecule you are interested in.

I have written this out at length because the short version keeps being misread.

33 likes in reply to #6 3mo

t.verhoevenTL26 May 2026#18

Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason a plain sequence comparison against native GLP-1 is misleading about how the molecule behaves.

32 likes 3mo

b.jansenTL216 May 2026#29

Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be clinically unimportant, which is not true of every injectable.

Happy to be corrected if someone holds better data than mine.

33 likes 2mo

t.wojcikTL220 May 2026#33

Right — I had this wrong and I am glad to have read it before it mattered.

28 likes 2mo

c.nybergTL22 Jun 2026#48

endpoint_line, post #24: The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice. Visible particles or frank cloudiness is different and would be reason to contact the supplier. Go to post

30 likes in reply to #24 2mo

h.oyelowoTL2Regular22 Jun 2026#73

Wickramasinghe, post #26: Grateful for the specificity. Vague answers to this question are what sent me looking. Go to post

A note on how semaglutide and gastric emptying gets discussed rather than on semaglutide and gastric emptying itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been right more often.

31 likes in reply to #26 1mo

p.mbekiTL29 Jul 2026#97

Where I have landed on semaglutide and gastric emptying, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it from somewhere that did not measure it.

33 likes 19d

NicolaidesTL3Regular12 Jul 2026#102

Post #101 is right about the mechanism and I think understates the practical bit.

Counterpoint on semaglutide and gastric emptying, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.

32 likes 15d

l.vukovicTL217 Jul 2026#109

formulary_notes, post #100: Semaglutide and gastric emptying is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is being asked for. Go to post

I had read the opposite somewhere and cannot now find where, which tells me something.

33 likes in reply to #100 11d

Read the full topic (123 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
Semaglutide and alcohol: what is actually documented Compounds › Semaglutide STEP programme randomised trial type 2 diabetes SELECT trial Posting this under the heading it deserves: Semaglutide and alcohol: what is actually documented Everything below is what sits behind that. I would like to know what people here actually do about semaglutide…	+14	18	10k	2d
The most common factual error about semaglutide on the internet — what changed since Compounds › Semaglutide effect size randomised trial SELECT trial type 2 diabetes The most common factual error about semaglutide on the internet — what changed since — setting out what I have, and where I think it stops being reliable. Putting the numbers in the first post, because a…	+42	46	1.7k	5mo
What the published dose-response for semaglutide actually looks like above 2.4 mg — a second dataset Compounds › Semaglutide STEP programme randomised trial SELECT trial type 2 diabetes Solved Asking directly, because I could not find a straight answer: What the published dose-response for semaglutide actually looks like above 2.4 mg — a second dataset Two things I would like separated before…	+112	130	2.2k	16mo
Semaglutide in people without diabetes: what the evidence base looks like Compounds › Semaglutide semaglutide effect size STEP programme randomised trial Semaglutide in people without diabetes: what the evidence base looks like Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of semaglutide…	+2	6	18k	17mo
Is there a ceiling dose beyond which semaglutide stops adding benefit? Compounds › Semaglutide effect size type 2 diabetes SELECT trial Is there a ceiling dose beyond which semaglutide stops adding benefit? I have a specific reason for asking rather than idle curiosity, and the context is below. Putting the numbers in the first post, because…		2	14k	2mo

Related topics — sharing the tags STEP programme, type 2 diabetes, randomised trial

Topic	Participants	Replies	Views	Activity
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Compounds › Semaglutide STEP programme type 2 diabetes randomised trial effect size Posting this under the heading it deserves: Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Everything below is what sits behind that. Putting the numbers in the first…	+125	132	39k	16mo
How to read a phase 2 result without treating it as a phase 3 result — what changed since Compounds › Retatrutide TRIUMPH programme randomised trial preprint Solved Asking directly, because I could not find a straight answer: How to read a phase 2 result without treating it as a phase 3 result — what changed since Putting the numbers in the first post, because a question…	+25	35	568	6mo
Reading a combination trial: attributing effect to components Compounds › Cagrilintide & amylin analogues cagrisema amylin analogues effect size cagrilintide Closed On the subject in the title: Reading a combination trial: attributing effect to components Working notes rather than a conclusion. Collecting what is known about reading a combination trial in one place,…		4	19k	11mo
Second opinions: how to seek one without burning the first Clinical › Prescriber conversations telehealth prior authorisation beginner friendly type 2 diabetes Closed Second opinions: how to seek one without burning the first Writing it up because I had to work it out twice and would rather nobody else did. The question about second opinions that I actually want answered…	+1	5	33k	19mo
Coming back to: Preparing for an appointment: one page, three questions Clinical › Prescriber conversations prior authorisation type 2 diabetes telehealth Posting this under the heading it deserves: Preparing for an appointment: one page, three questions Everything below is what sits behind that. A question about how to describe something to a clinician rather…	+139	151	47k	18mo